🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

National Database on Primary Sclerosing Cholangitis (PSC)

Recruitingn/aAges 17 Years - anyAllUniversity of Milano Bicocca
NCT05618145 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Primary sclerosing cholangitis (PSC) a rare, chronic fibroinflammatory disease of the liver. No data about the disease epidemiology exist in Italy. Therefore this study aims to develop a national PSC patient database linked to a biological sample storage.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Willing and able to give informed consent prior to any study specific procedure being performed; * Diagnosis of PSC according to the most recent published guidelines (EASL); Exclusion Criteria: * Subject unwilling to participate at the study
💊

What it tests

  • Clinical information
📍

Where

63 sites
Ospedali riuniti di Ancona
Ancona, Italy
Policlinico di Bari
Bari, Italy
ASST Bergamo ovest
Bergamo, Italy
ASST Papa Giovanni XXIII
Bergamo, Italy
Ospedale Sant'Orsola Malpighi
Bologna, Italy
Policlinico S. Orsola Malpighi
Bologna, Italy
Azienda sanitaria dell'Alto Adige
Bolzano, Italy
Spedali civili
Brescia, Italy

…and 55 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy